Edward J. Parr, Jr., the resident partner in the firm's Washington, DC office, specializes in mass tort litigation and manages the firm's mass tort group. His background includes pharmaceutical, dietary supplement, and medical device litigation as well as counseling on FDA regulatory matters, administrative law, and product liability issues. Martindale-Hubbell recognizes Mr. Parr as an AV rated attorney, the highest such rating available to any individual lawyer.
Originally from Greenwich, Connecticut, Mr. Parr attended New York University and earned his J.D. cum laude at the Georgetown University Law Center in 1993. Mr. Parr was admitted to practice law in the State of Louisiana in 1993 and the District of Columbia in 2002.
Mr. Parr is a former Assistant Chief Counsel at the United States Food and Drug Administration where he represented the agency in enforcement litigation under the Federal Food, Drug, and Cosmetic Act, and in actions brought under the Administrative Procedures Act and the Freedom of Information Act. He advised the agency on regulatory issues relating to a variety of prescription pharmaceuticals and medical devices including tobacco regulations and orthopedic bone screws. Upon leaving the FDA, Mr. Parr joined a private practice in Washington, D.C. to represent pharmaceutical and medical device companies on matters before the FDA, FTC, DEA, and CMS. Since 1998, Mr. Parr has worked with plaintiffs' attorneys around the country on mass tort litigations involving the drugs Pradaxa, Baycol, Rezulin, Propulsid, Phenylpropanolamine (PPA), the diet drugs Pondimin and Redux, ephedra, Vioxx, Prempro, and Trasylol, as well as implanted medical devices such as metal-on-metal hip replacements.
Mr. Parr is a member of the American Association for Justice (AAJ) and has been awarded AAJ's Weidman-Wysocki Citation for Excellence.